Kramer BS - Search Results

1

Biomarkers, subgroup evaluation, and clinical trial design.

Baker SG, Kramer BS, Sargent DJ, Bonetti M. Baker SG, et al. Among authors: kramer bs. Discov Med. 2012 Mar;13(70):187-92. Discov Med. 2012. PMID: 22463794 Review.

2

Variability in flexible sigmoidoscopy performance among examiners in a screening trial.

Pinsky PF, Schoen RE, Weissfeld JL, Kramer B, Hayes RB, Yokochi L; PLCO Project Team. Pinsky PF, et al. Clin Gastroenterol Hepatol. 2005 Aug;3(8):792-7. doi: 10.1016/s1542-3565(05)00286-7. Clin Gastroenterol Hepatol. 2005. PMID: 16234008

3

Validation: a critical step in bringing biomarkers to clinical fruition.

Srivastava S, Kramer BS. Srivastava S, et al. Among authors: kramer bs. Ann Epidemiol. 2018 Feb;28(2):135-138. doi: 10.1016/j.annepidem.2017.10.013. Epub 2017 Nov 9. Ann Epidemiol. 2018. PMID: 29157735

4

Extended mortality results for ovarian cancer screening in the PLCO trial with median 15years follow-up.

Pinsky PF, Yu K, Kramer BS, Black A, Buys SS, Partridge E, Gohagan J, Berg CD, Prorok PC. Pinsky PF, et al. Among authors: kramer bs. Gynecol Oncol. 2016 Nov;143(2):270-275. doi: 10.1016/j.ygyno.2016.08.334. Epub 2016 Sep 9. Gynecol Oncol. 2016. PMID: 27615399 Free PMC article. Clinical Trial.

5

Comprehensive Quality Management (CQM) in the PLCO Trial.

Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC. Gohagan JK, et al. Among authors: kramer bs. Rev Recent Clin Trials. 2015;10(3):223-32. doi: 10.2174/1574887110666150730121113. Rev Recent Clin Trials. 2015. PMID: 26238118

6

Early reporting for cancer screening trials.

Baker SG, Kramer BS, Prorok PC. Baker SG, et al. Among authors: kramer bs. J Med Screen. 2008;15(3):122-9. doi: 10.1258/jms.2008.007058. J Med Screen. 2008. PMID: 18927094 Free PMC article.

7

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.

Pinsky PF, Church TR, Izmirlian G, Kramer BS. Pinsky PF, et al. Among authors: kramer bs. Cancer. 2013 Nov 15;119(22):3976-83. doi: 10.1002/cncr.28326. Epub 2013 Aug 26. Cancer. 2013. PMID: 24037918 Free PMC article. Clinical Trial.

8

Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Crawford ED, Kramer BS, Andriole GL, Gelmann EP, Grubb R, Greenlee R, Gohagan JK. Pinsky PF, et al. Among authors: kramer bs. BJU Int. 2007 Apr;99(4):775-9. doi: 10.1111/j.1464-410X.2007.06708.x. Epub 2007 Jan 12. BJU Int. 2007. PMID: 17223921 Clinical Trial.

9

Prostate Cancer Screening - A Perspective on the Current State of the Evidence.

Pinsky PF, Prorok PC, Kramer BS. Pinsky PF, et al. Among authors: kramer bs. N Engl J Med. 2017 Mar 30;376(13):1285-1289. doi: 10.1056/NEJMsb1616281. N Engl J Med. 2017. PMID: 28355509 No abstract available.

10

The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.

Doroudi M, Kramer BS, Pinsky PF. Doroudi M, et al. Among authors: kramer bs. J Med Screen. 2017 Dec;24(4):220-222. doi: 10.1177/0969141316680381. Epub 2016 Nov 30. J Med Screen. 2017. PMID: 27903809 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results